UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 170

Sortiert nach

Pharmacogenetic predictor of extrapyramidal symptoms induced by antipsychotics: Multilocus interaction in the mTOR pathway

European neuropsychopharmacology, 2015-01, Vol.25 (1), p.51-59

2015

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival Benefit of Intensity Modulated Compared With 3D-Conformal Radiation Therapy in the Definitive Management of Esophageal Cancer: Analysis of the National Cancer Data Base (NCDB)

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S187-S187

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of Neoadjuvant Therapy on Peri-Operative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Cancer

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S87-S87

2013

Link zum Volltext

Verfügbarkeit prüfen

Long-term Efficacy and Toxicity of Hypofractionated Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E186-E186

2015

Link zum Volltext

Verfügbarkeit prüfen

Treatment Patterns and Outcomes Among Elderly Patients With Locally Advanced Esophageal Cancer: A National Cancer Data Base Analysis

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E163-E163

2016

Link zum Volltext

Verfügbarkeit prüfen

Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E242-E242

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased Pathologic Complete Response to Neoadjuvant Radiation in Rectal Cancer Patients Taking an Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S395-S395

2014

Link zum Volltext

Verfügbarkeit prüfen

Long Term Outcomes with Hypofractionated Radiotherapy (HFRT) for Clinically Localized Prostate Cancer: 70 Gy at 2.5 Gy per Fraction

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S53-S53

2014

Link zum Volltext

Verfügbarkeit prüfen

Quality of Life Outcomes from a Phase I/II Multi-institutional, Dose-per-Fraction Escalation Trial for Prostate Cancer

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S52-S53

2014

Link zum Volltext

Verfügbarkeit prüfen

Five-year Efficacy and Toxicity Outcomes from a Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S99-S99

2011

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated with Grade 3-4 Late Toxicity after Hypofractionated Prostate Salvage Radiation

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e429-e430

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer

International journal of radiation oncology, biology, physics, 2009-11, Vol.75 (3), p.S80-S81

2009

Link zum Volltext

Verfügbarkeit prüfen

Ki-67 Staining is a Strong Predictor of Patient Outcomes for Prostate Cancer Patients Treated on RTOG 94-08

International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S11-S12

2011

Link zum Volltext

Verfügbarkeit prüfen

Ten-Year Follow-Up on 160 Patients Treated with Hypofractionated Prostate Salvage Radiation Therapy

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e242-e243

2022

Link zum Volltext

Verfügbarkeit prüfen

Toxicity and Patient Reported Quality of Life Outcomes Following Prostate SBRT with Focal Boost to MRI Identified Prostate Cancer Lesions: Results of a Phase II Trial

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.S93

2022

Link zum Volltext

Verfügbarkeit prüfen

Daily Differences in Rectal Wall Irradiation for Hypofractionated Prostate Treatments on Helical Tomotherapy

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S650-S650

2009

Link zum Volltext

Verfügbarkeit prüfen

Hypofractionated Radiation Therapy for Clinically Localized Prostate Cancer: 70 Gy at 2.5 Gy per Fraction Revisited

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S316-S317

2008

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1/2 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With a Simultaneous Integrated Boost to MRI-Identified Regions of High Tumor Volume (NCT02470897)

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.E255-E255

2017

Link zum Volltext

Verfügbarkeit prüfen

Pelvic Nodal Dose Escalation in Conjunction with Hypofractionated IMRT for High Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S305-S305

2008

Link zum Volltext

Verfügbarkeit prüfen

Patient Reported Outcomes and Toxicity in a Phase I/II Trial of Prostate SBRT with a Simultaneous Integrated Boost to MRI-identified Tumor (NCT02470897)

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E296-E296

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase I/II Trial of Dose-per-Fraction Escalation for Prostate Cancer

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S174-S174

2007

Link zum Volltext

Verfügbarkeit prüfen

Variation in the Definition of Clinical Target Volumes for Postoperative Conformal Radiation Therapy of Prostate Cancer

International journal of radiation oncology, biology, physics, 2007-11, Vol.69 (3), p.S326-S326

2007

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Cardiac Toxicity in Operable Esophageal Cancer Patients Treated with or Without Chemoradiation

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.e44-e45

2018

Link zum Volltext

Verfügbarkeit prüfen

Klinisch stumme Hirninfarkte

Nervenarzt, 2011-08, Vol.82 (8), p.1043-1052

2011

Link zum Volltext

Verfügbarkeit prüfen

Schlaganfall immer mit Notarzt?“ – „Pro

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2013-06, Vol.108 (5), p.408-411

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(156)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(31)
Humans
(28)
Physics
(26)
Physical Sciences
(23)
Biological And Medical Sciences
(19)
Radiology
(17)
Hematology, Oncology And Palliative Medicine
(16)
Medical Sciences
(16)
Technology
(16)
Engineering
(12)
Male
(10)
Female
(9)
Psychiatry
(9)
Adult
(8)
Animals
(8)
Middle Aged
(7)
Nuclear Experiment
(7)
Protons
(7)
Chemistry
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenetic predictor of extrapyramidal symptoms induced by antipsychotics: Multilocus interaction in the mTOR pathway

Overall Survival Benefit of Intensity Modulated Compared With 3D-Conformal Radiation Therapy in the Definitive Management of Esophageal Cancer: Analysis of the National Cancer Data Base (NCDB)

Impact of Neoadjuvant Therapy on Peri-Operative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Cancer

Long-term Efficacy and Toxicity of Hypofractionated Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer

Treatment Patterns and Outcomes Among Elderly Patients With Locally Advanced Esophageal Cancer: A National Cancer Data Base Analysis

Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer

Increased Pathologic Complete Response to Neoadjuvant Radiation in Rectal Cancer Patients Taking an Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker

Long Term Outcomes with Hypofractionated Radiotherapy (HFRT) for Clinically Localized Prostate Cancer: 70 Gy at 2.5 Gy per Fraction

Quality of Life Outcomes from a Phase I/II Multi-institutional, Dose-per-Fraction Escalation Trial for Prostate Cancer

Five-year Efficacy and Toxicity Outcomes from a Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer

Factors Associated with Grade 3-4 Late Toxicity after Hypofractionated Prostate Salvage Radiation

A Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer

Ki-67 Staining is a Strong Predictor of Patient Outcomes for Prostate Cancer Patients Treated on RTOG 94-08

Ten-Year Follow-Up on 160 Patients Treated with Hypofractionated Prostate Salvage Radiation Therapy

Toxicity and Patient Reported Quality of Life Outcomes Following Prostate SBRT with Focal Boost to MRI Identified Prostate Cancer Lesions: Results of a Phase II Trial

Daily Differences in Rectal Wall Irradiation for Hypofractionated Prostate Treatments on Helical Tomotherapy

Hypofractionated Radiation Therapy for Clinically Localized Prostate Cancer: 70 Gy at 2.5 Gy per Fraction Revisited

A Phase 1/2 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With a Simultaneous Integrated Boost to MRI-Identified Regions of High Tumor Volume (NCT02470897)

Pelvic Nodal Dose Escalation in Conjunction with Hypofractionated IMRT for High Risk Prostate Cancer

Patient Reported Outcomes and Toxicity in a Phase I/II Trial of Prostate SBRT with a Simultaneous Integrated Boost to MRI-identified Tumor (NCT02470897)

A Phase I/II Trial of Dose-per-Fraction Escalation for Prostate Cancer

Variation in the Definition of Clinical Target Volumes for Postoperative Conformal Radiation Therapy of Prostate Cancer

Predictors of Cardiac Toxicity in Operable Esophageal Cancer Patients Treated with or Without Chemoradiation

Klinisch stumme Hirninfarkte

Schlaganfall immer mit Notarzt?“ – „Pro

Suchergebnisse filtern